Safety and efficacy of colistin and fluoroquinolone in neonatal persistent late-onset sepsis

Safety and efficacy of colistin and fluoroquinolone in neonatal persistent late-onset sepsis

Growing resistance of microorganisms to antibiotics for the treatment of late-onset sepsis (LOS) in premature infants has led physicians to use antibiotics that are not well studied in neonatal populations. We aimed to determine the efficacy and safety of colistin and fluoroquinolone for the treatme...

Full description

Bibliographic Details
Main Authors: Mountasser Al-Mouqdad, Khalid Eljaaly, Ayman Abdalgader, Maha Al-Anazi, Muhammed Taha, Arwa Alshaibani, Raneem Asfour, Thanaa Khalil, Suzan Asfour
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Saudi Pharmaceutical Journal
Subjects:
Multi-drug resistant organisms
Antibiotics
Colistin
Fluoroquinolone
Premature infants
Late-onset sepsis
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016421001419

Similar Items

Similar Items